Intra Cellular Therapies | Revenu Net



Net Income Changement Date
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
ALKERMES USD 367.07M 274.69M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
Halozyme Therapeutics USD 137.01M 1000 2024-12
Intra Cellular Therapies USD -16885000 9.44M 2024-12
J&J USD 3.43B 737M 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Prothena USD -57956000 1.04M 2024-12
RedHill Biopharma USD -1540000 0 2024-06
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12



Intra Cellular Therapies Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.